Lanini Simone, Costa Alessandro Nanni, Puro Vincenzo, Procaccio Francesco, Grossi Paolo Antonio, Vespasiano Francesca, Ricci Andrea, Vesconi Sergio, Ison Michael G, Carmeli Yehuda, Ippolito Giuseppe
Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
Italian National Transplant Center, Italian National Institute of Health (ISS), Rome, Italy.
PLoS One. 2015 Apr 2;10(4):e0123706. doi: 10.1371/journal.pone.0123706. eCollection 2015.
Bacterial infections remain a challenge to solid organ transplantation. Due to the alarming spread of carbapenem-resistant gram negative bacteria, these organisms have been frequently recognized as cause of severe infections in solid organ transplant recipients.
Between 15 May and 30 September 2012 we enrolled 887 solid organ transplant recipients in Italy with the aim to describe the epidemiology of gram negative bacteria spreading, to explore potential risk factors and to assess the effect of early isolation of gram negative bacteria on recipients' mortality during the first 90 days after transplantation. During the study period 185 clinical isolates of gram negative bacteria were reported, for an incidence of 2.39 per 1000 recipient-days. Positive cultures for gram negative bacteria occurred early after transplantation (median time 26 days; incidence rate 4.33, 1.67 and 1.14 per 1,000 recipient-days in the first, second and third month after SOT, respectively). Forty-nine of these clinical isolates were due to carbapenem-resistant gram negative bacteria (26.5%; incidence 0.63 per 1000 recipient-days). Carbapenems resistance was particularly frequent among Klebsiella spp. isolates (49.1%). Recipients with longer hospital stay and those who received either heart or lung graft were at the highest risk of testing positive for any gram negative bacteria. Moreover recipients with longer hospital stay, lung recipients and those admitted to hospital for more than 48h before transplantation had the highest probability to have culture(s) positive for carbapenem-resistant gram negative bacteria. Forty-four organ recipients died (0.57 per 1000 recipient-days) during the study period. Recipients with at least one positive culture for carbapenem-resistant gram negative bacteria had a 10.23-fold higher mortality rate than those who did not.
The isolation of gram-negative bacteria is most frequent among recipient with hospital stays >48 hours prior to transplant and in those receiving either heart or lung transplants. Carbapenem-resistant gram negative isolates are associated with significant mortality.
细菌感染仍然是实体器官移植面临的一项挑战。由于耐碳青霉烯类革兰氏阴性菌的惊人传播,这些微生物经常被认为是实体器官移植受者严重感染的病因。
2012年5月15日至9月30日期间,我们在意大利招募了887名实体器官移植受者,目的是描述革兰氏阴性菌传播的流行病学特征,探索潜在风险因素,并评估早期隔离革兰氏阴性菌对移植后前90天受者死亡率的影响。在研究期间,报告了185株革兰氏阴性菌临床分离株,发病率为每1000个受者日2.39例。革兰氏阴性菌阳性培养物在移植后早期出现(中位时间26天;实体器官移植后第一个月、第二个月和第三个月的发病率分别为每1000个受者日4.33例、1.67例和1.14例)。这些临床分离株中有49株是耐碳青霉烯类革兰氏阴性菌(26.5%;发病率为每1000个受者日0.63例)。碳青霉烯类耐药在克雷伯菌属分离株中尤为常见(49.1%)。住院时间较长的受者以及接受心脏或肺移植的受者检测出任何革兰氏阴性菌呈阳性的风险最高。此外,住院时间较长的受者、肺移植受者以及移植前住院超过48小时的受者培养出耐碳青霉烯类革兰氏阴性菌呈阳性的可能性最高。在研究期间,44名器官受者死亡(每1000个受者日0.57例)。至少有一次耐碳青霉烯类革兰氏阴性菌培养呈阳性的受者死亡率比未出现阳性的受者高10.23倍。
革兰氏阴性菌的分离在移植前住院时间>48小时的受者以及接受心脏或肺移植的受者中最为常见。耐碳青霉烯类革兰氏阴性菌分离株与显著的死亡率相关。